Top

Published in:

01-04-2020 | Dystonia | Letter to the Editor

Persistent dystonia and basal ganglia involvement following metronidazole induced encephalopathy

Authors: Abdolmajid Omrani, Mohammad Rohani, Sareh Hosseinpour, Ali Reza Tavasoli

Published in: Neurological Sciences | Issue 4/2020

Excerpt

Metronidazole is an antimicrobial agent, widely used in treatment of infectious diseases [1, 2]. Since 1978, numerous patients have been reported with neurological complications of metronidazole such as peripheral neuropathy, motor lateralized impairment, cerebellar dysfunction (ataxia, dysarthria and dysmetria), oculomotor disturbances, visual impairment (nystagmus), vestibulocochlear toxicity, dysarthria, seizure, and encephalopathy [1]. It rarely induces movement disorder [2‐4]. In most reported patients, these complications have been reversible without neurologic sequels [1‐5]. Herein, we report a young patient with persistent generalized dystonia and basal ganglia involvement following metronidazole toxicity. …

Available only for authorised users

Roy U, Panwar A, Pandit A, Das SK, Joshi B (2016) Clinical and neuroradiological spectrum of metronidazole induced encephalopathy: our experience and the review of literature. J Clin Diagn Res 10(6):OE01–OE09PubMedPubMedCentral

Lee HC, Kim YE, Ma HI (2017) Metronidazole-induced craniocervical myoclonus with reversible bilateral dentate nucleus lesions. J Mov Disord 10(1):67–68CrossRef

Yagi T, Shihashi G, Oki K, Suzuki S, Shinoda M, Itano O, Kitagawa Y, Suzuki N (2015) Metronidazole-induced encephalopathy and myoclonus: case report and a review of the literature. Neurol Clin Neurosci 3(3):111–113CrossRef

Galvez M, Brahm J, Miranda M (2009) Movement disorders as a manifestation of metronidazole-induced encephalopathy in a patient with chronic liver disease. Mov Disord 24(12):1864–1866CrossRef

Sørensen CG1, Karlsson WK, Amin FM, Lindelof M (2018) Metronidazole-induced encephalopathy: a systematic review. J Neurol pp 1-13. https://doi.org/10.1007/s00415-018-9147-6

Cantador AA, Meschia JF, Freeman WD, Tatum WO (2013) Nonconvulsive status with metronidazole. Neurohospitalist 3(4):185–189CrossRef

Foreid H, Coelho M, Ferreira J, Ferro JM (2009) Reversible iatrogenic subacute cerebellar syndrome, myoclonus and MRI findings followingmetronidazole administration.BMJ Case Rep. http://dx.doi.org/10.1136/bcr.05.2009.1841

Hobbs K, Stern-Nezer S, Buckwalter MS, Fischbein N, Finley Caulfield A (2015) Metronidazole-induced encephalopathy: not always a reversible situation. Neurocrit Care 22(3):429–436CrossRef

Groothoff MVR, Hofmeijer J, Sikma MA, Meulenbelt J (2010) Irreversible encephalopathy after treatment with high-dose intravenous metronidazole. Clin Ther 32(1):60–64CrossRef

10.

Kuriyama A, Jackson JL, Doi A, Kamiya T (2011) Metronidazole-induced central nervous system toxicity : a systematic review. Clin Neuropharmacol 34(6):241–247CrossRef

Title: Persistent dystonia and basal ganglia involvement following metronidazole induced encephalopathy
Authors: Abdolmajid Omrani
Mohammad Rohani
Sareh Hosseinpour
Ali Reza Tavasoli
Publication date: 01-04-2020
Publisher: Springer International Publishing
Keywords: Dystonia
Cranial MRI
Metronidazole
Movement Disorder
Encephalopathy
Published in: Neurological Sciences / Issue 4/2020
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-019-04091-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Persistent dystonia and basal ganglia involvement following metronidazole induced encephalopathy

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2020

Restless legs syndrome and its variants: a case report

Acute compressive radial neuropathy and wrist drop due to the repetitive overuse of the arm

Integrated care pathways on dementia in Italy: a survey testing the compliance with a national guidance

Self-perceptions on cognitive versus motor disability among neurologists

Identification of common genetic markers of paroxysmal neurological disorders using a network analysis approach

Constructional apraxia from the roots up: Kleist, Strauss, and their contemporaries